Bridging the Gap to Early Support in MS
What Would You Do? Engaging in Evidence-based Treatment Approaches for Multiple Sclerosis
Beyond the Horizon: Optimizing Long-Term Outcomes in Neuromyelitis Optica Spectrum Disorder with Innovative Therapies
The Hidden Side of Multiple Sclerosis (MS): Harnessing Key Pathologies to Improve Outcomes Across the MS Spectrum
Taking a Closer Look at Each Patient: Exploring Novel Biomarker and Imaging Strategies
This program will review evidence-based guidelines for diagnosis of neuromyelitis optica spectrum disorder (NMOSD) and discuss the use of approved biologics that have been shown to enhance patient outcomes. Expert faculty will share insights on the latest evidence-based diagnostic and treatment methods hoping to improve early detection and overall patient management in a disease that is commonly misdiagnosed in its early stages. Experts will also discuss a clinical case to highlight best practices and interprofessional strategies to advance the quality of care for patients with NMOSD.